Pupillary dilation a must for OCT

Article

High quality optical coherence tomography (OCT) images cannot be obtained in a large percentage of glaucoma patients without pupillary dilation.

High quality optical coherence tomography (OCT) images cannot be obtained in a large percentage of glaucoma patients without pupillary dilation, according to a report published in the December issue of the British Journal of Ophthalmology.

Michael Smith from Torbay Hospital, Devon, UK and colleagues from the Peninsula Medical School and the University of Plymouth, Devon conducted an observational study of 38 patients attending a glaucoma clinic in order to examine the effect of pupillary dilation on the reliability of retinal nerve fibre layer (RNFL) and optic nerve head (ONH) assessments using the Stratus OCT (Carl Zeiss). The "fast optic disc" and "fast RNFL thickness" programmes on the Stratus were used to measure the RNFL thickness and ONH cup-to-disc ratio (CDR). Two scans were performed prior to dilation and two following dilation with tropicamide 1% drops.

In nine patients (23.7%) no images were obtained prior to dilation however, following dilation, examination was possible in all patients. Inability to obtain an undilated scan was associated with smaller pupil size and increasing cataract. The scan quality, as determined by the signal strength score, was higher when pupils were dilated for both RNFL thickness (p=0.011) and ONH CDR (p=0.007).

The authors of this study believe that attaining high quality OCT images is not possible without pupillary dilation, in about 25% of patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.